Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Natural Products

• Publication date

  1999-03-25

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1021/NP980553BPMID 10217737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.

  1998cited by this paper
• Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.

  1998cited by this paper
• Progress in the discovery of biosynthetic anticancer drugs.

  1996cited by this paper
• Dendroamides, new cyclic hexapeptides from a blue-green alga. Multidrug-resistance reversing activity of dendroamide A.

  1996cited by this paper
• Cyclic peptides and depsipeptides from cyanobacteria: A review

  1996cited by this paper
• Microcolins A and B, new immunosuppressive peptides from the blue-green alga Lyngbya majuscula.

  1992cited by this paper
• Lyngbyatoxins B and C, two new irritants from Lyngbya majuscula.

  1990cited by this paper
• Seaweed dermatitis: structure of lyngbyatoxin A.

  1979cited by this paper
• Aplysiatoxin and debromoaplysiatoxin, constituents of the marine mollusk Stylocheilus longicauda (Quoy and Gaimard, 1824).

  1974cited by this paper

• Distribution Ecology and Epifaunal Assemblages of the Cyanobacteria (Symploca hydnoides) Are affected by Abiotic Factors of Surface Water in Tropical Islands

  2025influential citation
• Something 'Old, New, Borrowed, or Blue', the Search for Mother Nature's Bioactive Agents.

  2024cites this paper
• Modified peptides and organic metabolites of cyanobacterial origin with antiplasmodial properties

  2024cites this paper
• Antioxidant micropeptins from a Microcoleus autumnalis-dominated benthic cyanobacterial mat from Western Ireland.

  2024cites this paper
• Marine Organisms as a Prolific Source of Bioactive Depsipeptides

  2023cites this paper
• Dolastatins and their analogues present a compelling landscape of potential natural and synthetic anticancer drug candidates

  2023cites this paper
• Cyanobacteria Natural Products as Sources for Future Directions in Antibiotic Drug Discovery

  2023cites this paper
• Recent advances on marine mollusk-derived natural products: chemistry, chemical ecology and therapeutical potential.

  2022cites this paper
• The intriguing chemistry and biology of sulfur-containing natural products from marine microorganisms (1987–2020)

  2021cites this paper
• Ahp-Cyclodepsipeptides as tunable inhibitors of human neutrophil elastase and kallikrein 7: Total synthesis of tutuilamide A, serine protease selectivity profile and comparison with lyngbyastatin 7.

  2020cites this paper
• Extracting value: mechanistic insights into the formation of natural product artifacts - case studies in marine natural products.

  2020cites this paper
• Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF-1α Mediated Cancer Cell Viability and Vascularization.

  2020cites this paper
• From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-cyclodepsipeptides.

  2020cites this paper
• Tutuilamides A-C: Vinyl-Chloride Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.

  2020cites this paper
• 1 Natural products from cyanobacteria : focus on 2 beneficial activities 3

  2019cites this paper
• Cyanobacterial bioactive metabolites-A review of their chemistry and biology.

  2019cites this paper
• Cyanobacterial bioactive metabolites-A review of their chemistry and biology.

  2019cites this paper
• Built to bind: biosynthetic strategies for the formation of small-molecule protease inhibitors.

  2019cites this paper
• Kyanamide, a new Ahp-containing depsipeptide from marine cyanobacterium Caldora penicillata

  2019cites this paper
• Marine natural products as strategic prototypes in the development of a new generation of antimalarial agents

  2019cites this paper
• Environmental and cultured cyanobacteria as sources of Aedes aegypti larvicides

  2019cites this paper
• Natural Products from Cyanobacteria: Focus on Beneficial Activities

  2019cites this paper
• Plants That Fight Cancer

  2019cites this paper
• Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

  2018cites this paper
• Metabolomics-Guided Discovery of Microginin Peptides from Cultures of the Cyanobacterium Microcystis aeruginosa.

  2018cites this paper
• Dolabellol A, a New Halogenated Diterpene Isolated from the Opisthobranch Dolabella auricularia

  2017cites this paper
• Antifungal and Antiviral Cyclic Peptides from the Deep-Sea-Derived Fungus Simplicillium obclavatum EIODSF 020.

  2017cites this paper
• Xylapeptide A, an Antibacterial Cyclopentapeptide with an Uncommon L-Pipecolinic Acid Moiety from the Associated Fungus Xylaria sp. (GDG-102)

  2017cites this paper
• Synthesis and Structure Revision of Symplocin A.

  2017cites this paper
• THE EFFECT OF SOME FRESH WATER ALGEA EXTRACTS IN THE INHIBITION OF THE GROWTH OF SOME MICROORGANISIM THAT CAUSE FOOD SPOILAGE

  2016cites this paper
• DRUGS FROM THE SEA: A REVIEW OF MARINE DRUGS IN THE PIPELINE AND THE CHALLENGES FACED BY RESEARCHERS IN MARINE DRUG DEVELOPMENT.

  2015cites this paper
• Recent advances in the development of new auristatins: structural modifications and application in antibody drug conjugates.

  2015cites this paper
• The Potential of Peptides and Depsipeptides from Terrestrial and Marine Organisms in the Fight against Human Protozoan Diseases

  2015cites this paper
• Effect of Spirulina platensis Supplementation on Nutritional and Biochemical Parameters of Under Five Years Malnourished Children from an Orphanage in Douala, Cameroon

  2015cites this paper
• Improved Total Synthesis and Biological Evaluation of Potent Apratoxin S4 Based Anticancer Agents with Differential Stability and Further Enhanced Activity

  2014cites this paper
• Kurahamide, a Cyclic Depsipeptide Analog of Dolastatin 13 from a Marine Cyanobacterial Assemblage of Lyngbya sp.

  2014cites this paper
• Lumazine peptides penilumamides B-D and the cyclic pentapeptide asperpeptide A from a gorgonian-derived Aspergillus sp. fungus.

  2014cites this paper
• Evaluación como acondicionador de suelo y a nivel de laboratorio, de un consorcio previamente seleccionado de microalgas y cianobacterias con predominio de Calothrix sp

  2014cites this paper
• α,β-Dehydroamino acids in naturally occurring peptides

  2014cites this paper
• Effect of antibacterial properties of cyanobacterial Spirulina platensis

  2013cites this paper
• Isolation of ciliatamide D from a marine sponge Stelletta sp. and a reinvestigation of the configuration of ciliatamide A.

  2013cites this paper
• Total synthesis of (29S,37S)-isomer of malevamide E, a potent ion-channel inhibitor.

  2013cites this paper
• Novel Bioactive Peptides from Cyanobacteria: Functional, Biochemical, and Biomedical Significance

  2012cites this paper
• A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites

  2012cites this paper
• Aplisulfamines, New Sulfoxide-Containing Metabolites from an Aplidium Tunicate: Absolute Stereochemistry at Chiral Sulfur and Carbon Atoms Assigned Through an Original Combination of Spectroscopic and Computational Methods

  2012cites this paper
• Proteins and peptides as anticancer agents

  2011cites this paper
• Peptides and Proteins Increase Mineral Absorption and Improve Bone Condition

  2011cites this paper
• Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis.

  2010cites this paper
• Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.

  2010cites this paper
• Penilumamide, a novel lumazine peptide isolated from the marine-derived fungus, Penicillium sp. CNL-338.

  2010cites this paper
• Bioactive metabolites from microorganisms

  2009cites this paper
• Tiglicamides A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides.

  2009cites this paper
• FACILE SYNTHESES OF THREE AHP-TYPE BUILDING BLOCKS WITH COMPLEMENTARY REACTIVITIES

  2009cites this paper
• Pompanopeptins A and B, new cyclic peptides from the marine cyanobacterium Lyngbya confervoides

  2008cites this paper
• Systems biology of cyanobacterial secondary metabolite production and its role in drug discovery

  2008cites this paper
• Isolation and structure determination of malevamide E, a dolastatin 14 analogue, from the marine cyanobacterium Symploca laete-viridis.

  2008cites this paper
• Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp.

  2008cites this paper
• Carriebowmide, a new cyclodepsipeptide from the marine cyanobacterium Lyngbya polychroa.

  2008cites this paper
• On the Evolution of Nonribosomal Peptide Synthetase Gene Clusters in Cyanobacteria

  2007cites this paper
• Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp.

  2007cites this paper
• On the Evolution of Nonribosomal Peptide Synthetase Gene Clusters in Cyanobacteria

  2007cites this paper
• Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

  2007cites this paper
• Spirulina and Antibacterial Activity

  2007cites this paper
• Halogenated cyclic peptides isolated from the sponge Corticium sp.

  2007cites this paper
• The Bogorol family of antibiotics: template-based structure elucidation and a new approach to positioning enantiomeric pairs of amino acids.

  2006cites this paper
• Cyanobacterial peptides - nature's own combinatorial biosynthesis.

  2006influential citation
• Isolation and structure of phakellistatin 14 from the Western Pacific marine sponge Phakellia sp.

  2005cites this paper
• The Dolastatins: Novel Antitumor Agents from Dolabella auricularia

  2005cites this paper
• Chemistry and biology of cyclic depsipeptides of medicinal and biological interest.

  2004cites this paper
• Morphological, Chemical, and Genetic Diversity of Tropical Marine Cyanobacteria Lyngbya spp. and Symploca spp. (Oscillatoriales)

  2004cites this paper
• Characterization of Anabaena cyanobacteria: repeated sequences and genes involved in biosynthesis of microcystins and anabaenopeptilides

  2004cites this paper
• Tasipeptins A and B: new cytotoxic depsipeptides from the marine cyanobacterium Symploca sp.

  2003cites this paper
• The isolation and structure elucidation of Tasiamide B, a 4-amino-3-hydroxy-5-phenylpentanoic acid containing peptide from the marine Cyanobacterium Symploca sp.

  2003cites this paper
• The guineamides, novel cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula.

  2003cites this paper
• Isolation and structure determination of lyngbyastatin 3, a lyngbyastatin 1 homologue from the marine cyanobacterium Lyngbya majuscula. Determination of the configuration of the 4-amino-2,2-dimethyl-3-oxopentanoic acid unit in majusculamide C, dolastatin 12, lyngbyastatin 1, and lyngbyastatin 3 from

  2003cites this paper
• Marine natural products.

  2003cites this paper
• Peptides with anticancer use or potential

  2003cites this paper
• The widespread distribution of natural products

  2002cites this paper
• Total synthesis of somamide A, an Ahp (3-amino-6-hydroxy-2-piperidone)-containing cyclic depsipeptide

  2002cites this paper
• Malevamide D: isolation and structure determination of an isodolastatin H analogue from the marine cyanobacterium Symploca hydnoides.

  2002cites this paper
• Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452.

  2002cites this paper
• Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp.

  2002cites this paper
• The cyanobacterial origin of potent anticancer agents originally isolated from sea hares.

  2002cites this paper
• Symbiotic and dietary marine microalgae as a source of bioactive molecules–experience from natural products research

  2002cites this paper
• The chemistry and chemical ecology of biologically active cyanobacterial metabolites

  2002cites this paper
• Nitrogen-containing metabolites from marine cyanobacteria.

  2001cites this paper
• Georgamide, a new cyclic depsipeptide with an alkynoic acid residue from an Australian cyanobacterium.

  2001cites this paper
• Marine sulfur-containing natural products

  2001cites this paper
• Marine natural products.

  2001cites this paper
• Somamides A and B, two new depsipeptide analogues of dolastatin 13 from a Fijian cyanobacterial assemblage of Lyngbya majuscula and Schizothrix species.

  2001cites this paper
• Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

  2001cites this paper
• Biochemical and pharmacological investigations of selected cyanobacteria.

  2001cites this paper
• A new indanone from the marine cyanobacterium Lyngbya majuscula that inhibits hypoxia-induced activation of the VEGF promoter in Hep3B cells.

  2000cites this paper
• Antineoplastic agents from natural sources: achievements and future directions

  2000cites this paper
• Search and Discovery Strategies for Biotechnology: the Paradigm Shift

  2000cites this paper
• Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majuscula.

  2000cites this paper
• Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula.

  1999cites this paper